Matthias Geyer

16.3k total citations · 3 hit papers
201 papers, 10.8k citations indexed

About

Matthias Geyer is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Matthias Geyer has authored 201 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 44 papers in Virology and 40 papers in Immunology. Recurrent topics in Matthias Geyer's work include HIV Research and Treatment (44 papers), RNA Research and Splicing (27 papers) and Inflammasome and immune disorders (24 papers). Matthias Geyer is often cited by papers focused on HIV Research and Treatment (44 papers), RNA Research and Splicing (27 papers) and Inflammasome and immune disorders (24 papers). Matthias Geyer collaborates with scholars based in Germany, United States and France. Matthias Geyer's co-authors include B. Matija Peterlin, Hans Robert Kalbitzer, O. Fackler, Dirk Eick, Alfred Wittinghofer, André Schönichen, Christian A. Bösken, Sonja Kühn, Eicke Latz and Rebecca Brinkschulte and has published in prestigious journals such as Nature, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

Matthias Geyer

198 papers receiving 10.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease

2017 708 citations Matthias Geyer, Eicke Latz et al. Nature profile →
Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3

2022 178 citations Inga V. Hochheiser, Gregor Hagelueken et al. Nature profile →
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants

2025 24 citations Shouya Feng, Katja Hrovat-Schaale et al. Nature Immunology profile →

Peers

Countries citing papers authored by Matthias Geyer

Since Specialization

Citations

This map shows the geographic impact of Matthias Geyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Geyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Geyer more than expected).

Fields of papers citing papers by Matthias Geyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Geyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Geyer. The network helps show where Matthias Geyer may publish in the future.

Co-authorship network of co-authors of Matthias Geyer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Geyer. A scholar is included among the top collaborators of Matthias Geyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Geyer. Matthias Geyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets 2025 ·Nature Immunology ·Alexander N.R. Weber, Róisín M. McManus, Veit Hornung, Matthias Geyer, Jasmin Kuemmerle‐Deschner, Eicke Latz	3
2	Discovery of an allosteric binding site for anthraquinones at the human P2X4 receptor 2025 ·Nature Communications ·(unknown), Vigneshwaran Namasivayam, (unknown), (unknown), Younis Baqi, (unknown), Aliaa Abdelrahman, (unknown), (unknown), (unknown), (unknown), Jan Kubíček, Barbara Maertens, Matthias Geyer, (unknown), Annette Nicke, Gregor Hagelueken, Christa E. Müller	1
3	Clustering of NLRP3 induced by membrane or protein scaffolds promotes inflammasome assembly 2025 ·Nature Communications ·(unknown), (unknown), (unknown), Mateja Erdani Kreft, Matthias Geyer, Roman Jerala, Iva Hafner‐Bratkovič	3
4	Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants breakdown → 2025 ·Nature Immunology ·Shouya Feng, (unknown), Katja Hrovat-Schaale, (unknown), Yaoyuan Zhang, (unknown), Paul J. Baker, (unknown), Annemarie Steiner, Dominic De Nardo, Dhanya Lakshmi Narayanan, Florian Milhavet, Alberto Pinzón‐Charry, Juan I. Aróstegui, Raju Khubchandani, Matthias Geyer, Guilaine Boursier, Seth L. Masters	24
5	Actin associates with actively elongating genes and binds directly to the Cdk9 subunit of P-TEFb 2024 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), Maximilian Schmitz, (unknown), Matthias Geyer, Maria K. Vartiainen	1
6	Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application 2024 ·Nature Communications ·Lisa D. J. Schiffelers, Yonas M. Tesfamariam, Lea‐Marie Jenster, (unknown), (unknown), Sabine Normann, (unknown), (unknown), (unknown), (unknown), Assaf Alon, Matthias Geyer, Hidde L. Ploegh, Florian I. Schmidt	12
7	Discovery and design of molecular glue enhancers of CDK12–DDB1 interactions for targeted degradation of cyclin K 2024 ·RSC Chemical Biology ·(unknown), Maximilian Schmitz, (unknown), Solomon Tadesse, (unknown), (unknown), (unknown), Vinayak Palve, (unknown), K. Anand, Sylvia M. Frydman, William Roush, E. Schönbrunn, Matthias Geyer, Derek R. Duckett, Andrii Monastyrskyi	3
8	The SAVED domain of the type III CRISPR protease CalpL is a ring nuclease 2024 ·Nucleic Acids Research ·(unknown), (unknown), Maximilian Schmitz, Marianne Engeser, Matthias Geyer, Christophe Rouillon, Gregor Hagelueken	5
9	Pyroptosis inhibiting nanobodies block Gasdermin D pore formation 2023 ·Nature Communications ·(unknown), Gregor Hagelueken, (unknown), Jonas Moecking, Lisa D. J. Schiffelers, Florian I. Schmidt, Matthias Geyer	14
10	Insights into the molecular basis and mechanism of heme‐triggered TLR4 signalling: The role of heme‐binding motifs in TLR4 and MD2 2023 ·Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Maria A. Miteva, (unknown), Matthias Geyer, Bénédicte Manoury, Nicolas S. Merle, Lubka T. Roumenina, Marcelo T. Bozza, Günther Weindl, Diana Imhof	10
11	Functional characterization of the human Cdk10/Cyclin Q complex 2022 ·Open Biology ·Robert Düster, Yanlong Ji, Kuan‐Ting Pan, Henning Urlaub, Matthias Geyer	11
12	Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation 2022 ·Science Advances ·Inga V. Hochheiser, (unknown), Gregor Hagelueken, Juan F. Rodríguez-Alcázar, (unknown), Eicke Latz, Elmar Behrmann, Matthias Geyer	44
13	Deficiency in coatomer complex I causes aberrant activation of STING signalling 2022 ·Nature Communications ·Annemarie Steiner, Katja Hrovat-Schaale, Ignazia Prigione, Chien‐Hsiung Yu, Pawat Laohamonthonkul, Cassandra R. Harapas, Ronnie Ren Jie Low, Dominic De Nardo, Laura F. Dagley, Michael J. Mlodzianoski, Kelly L. Rogers, Thomas Zillinger, Gunther Hartmann, Michael P. Gantier, Marco Gattorno, Matthias Geyer, Stefano Volpi, Sophia Davidson, Seth L. Masters	63
14	P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection 2022 ·The Journal of Experimental Medicine ·Lea‐Marie Jenster, (unknown), Sabine Normann, (unknown), Jennifer Deborah Wuerth, Lisa D. J. Schiffelers, Yonas M. Tesfamariam, Florian N. Gohr, (unknown), Ines H. Kaltheuner, (unknown), (unknown), Jacob Mayer, Jonas Moecking, Hidde L. Ploegh, Eicke Latz, Felix Meissner, Matthias Geyer, Beate M. Kümmerer, Florian I. Schmidt	67
15	The contribution of intermolecular spin interactions to the London dispersion forces between chiral molecules 2022 ·The Journal of Chemical Physics ·Matthias Geyer, Rafael Gutiérrez, Vladimiro Mújica, J.F. Rivas‐Silva, Arezoo Dianat, Gianaurelio Cuniberti	12
16	Antiviral signalling by a cyclic nucleotide activated CRISPR protease 2022 ·Nature ·Christophe Rouillon, (unknown), (unknown), (unknown), Stefano Da Vela, Katrin Ackermann, Jonas Moecking, M. Peter, (unknown), Reinhard Seifert, Bela E. Bode, Jonathan L. Schmid‐Burgk, Dmitri I. Svergun, Matthias Geyer, Malcolm F. White, Gregor Hagelueken	30
17	Discovery and resistance mechanism of a selective CDK12 degrader 2021 ·Nature Chemical Biology ·Baishan Jiang, Yang Gao, Jianwei Che, Wenchao Lu, Ines H. Kaltheuner, Ruben Dries, Marian Kalocsay, Matthew J. Berberich, Jie Jiang, Inchul You, Nicholas Kwiatkowski, Kristin M. Riching, Danette L. Daniels, Peter K. Sorger, Matthias Geyer, Tinghu Zhang, Nathanael S. Gray	96
18	MIR sequences recruit zinc finger protein ZNF768 to expressed genes 2018 ·Nucleic Acids Research ·Rohrmoser Michaela, Michael Kluge, (unknown), Gruber-Eber Anita, Muhammad Ahmad Maqbool, Ignasi Forné, Stefan Krebs, Helmut Blum, Ann Katrin Greifenberg, Matthias Geyer, Nicolas Descostes, Axel Imhof, Jean‐Christophe Andrau, Caroline C. Friedel, Dirk Eick	15
19	Reacquisition of Nef-Mediated Tetherin Antagonism in a Single In Vivo Passage of HIV-1 through Its Original Chimpanzee Host 2012 ·Cell Host & Microbe ·(unknown), Daniel Sauter, Shariq M. Usmani, Joëlle V. Fritz, Christine Goffinet, Anke Heigele, Matthias Geyer, Frédéric Bibollet‐Ruche, Gerald H. Learn, O. Fackler, Beatrice H. Hahn, Frank Kirchhoff	29
20	Polyamine spider toxins and NMDA receptors: structural basis for channel block and binding of argiotoxin636 1996 ·FEBS Journal ·(unknown), Matthias Geyer, Hans Robert Kalbitzer, J. P. Ruppersberg, Werner Jahn, Veit Witzemann	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact